ARROWHEAD PHARMACEUTICALS, INC.

ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000879407

Price chart

Open-market purchases and sales by ARWR insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Aug 20, 20265:25 PM ETAug 18, 2026OLUKOTUN ADEOYE YDirectorSSaleCommon Stock−2K$86.96−$173.92K31.6K−6.0%SEC
Aug 20, 20265:22 PM ETAug 18, 2026PERRY MICHAEL SDirectorSSaleCommon Stock−11.6K$87.30−$1.01M111.46K−9.4%SEC
May 14, 2026May 12, 2026Lu HongboDirectorSSaleCommon Stock−2.97K$76.88−$228.33K52.01K−5.4%SEC10b5-1
Apr 24, 2026Apr 23, 2026Hamilton James CChief Medical OfficerSSaleCommon Stock−10K$75.00−$750K226.96K−4.2%SEC10b5-1
Apr 24, 2026Apr 22, 2026Apel Daniel JosephChief Financial OfficerSSaleCommon Stock−13.1K$71.3467−$934.29K162.91K−7.4%SEC10b5-1

The largest institutional positions in ARWR at the end of Q2 2026.

Institutions holding ARWR in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.14,830,553$1.21B0.02%−3,330,966−18.3%Reduced
Avoro Capital Advisors LLC11,355,555$925.59M8.31%+655,556+6.1%Added
FMR LLC8,039,804$655.32M0.03%+773,152+10.6%Added
VANGUARD PORTFOLIO MANAGEMENT LLC6,351,355$517.7M0.02%−794,781−11.1%Reduced
VANGUARD CAPITAL MANAGEMENT LLC6,110,953$498.1M0.01%+78,537+1.3%Added